Drug General Information (ID: D1721)
  Drug Name
Zileuton
  Drug Type Small molecule
  Drug Synonymous
Leutrol; Zileutonum; Ziluton; Zyflo; Abbott brand of zileuton; Zyflo CR; Zyflo Filmtab; A 64077; Abbot 64077; Abbott 64077; A-64077; ABBOTT-64077; ABT-077; CTI-02; ZYFLO (TN); ZYFLO, Zileuton; Zileutonum [INN-Latin]; Zyflo (TN); Zileuton (USP/INN); Zileuton [USAN:INN:BAN]; N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea; N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea; (+-)-1-(1-Benzo(b)thien-2-ylethyl)-1-hydroxyurea; (+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea; (+/-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea; 1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea; 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
    Click to Show/Hide
  Disease Class CA23: Asthma
  Therapeutic Class Antiinflammatory Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C11H12N2O2S
  InChI 1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)
  InChIKey MWLSOWXNZPKENC-UHFFFAOYSA-N
  Canonical SMILES CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
  External Link
Pubchem ID 60490
CAS Number 111406-87-2
CHEBI ID 10112
TTD ID D09JUG
INTEDE ID DR1730

Drug-Drug Interaction Network
  Sunburst Graph
AM004  Affected intra/extra-hepatic metabolism
AM005  Affected excretion pathways
AM006  Pharmacodynamic additive effects
BM017  CYP450 enzyme inhibition
BM022  CYP450 enzyme induction
BM024  Competitive inhibition of metabolic enzyme
BM025  Decreased metabolism (Unspecific)
BM032  Decreased renal excretion (Unspecific)
BM055  Increased risk of hepatotoxicity
  Relation Graph
 Full list of drugs interacting with Zileuton
      Affected intra/extra-hepatic metabolism
   CYP450 enzyme inhibition Drug Num:  66
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1596
 
Tizanidine
 
C9H8ClN5S
 
5487 
Major    Inter Info   
[3], [4], [5], [6], [7], [8], [9], [10]
D0944
 
Lomitapide
 
C39H37F6N3O2
 
9853053 
Major    Inter Info   
[14]
D1292
 
Pimozide
 
C28H29F2N3O
 
16362 
Major    Inter Info   
[17], [18], [19], [20], [21], [22], [23], [24], [25]
D1385
 
Rasagiline
 
C12H13N
 
3052776 
Major    Inter Info   
[17], [26], [27]
D0084
 
Anagrelide
 
C10H7Cl2N3O
 
135409400 
Moderate    Inter Info   
[28]
D0115
 
Astemizole
 
C28H31FN4O
 
2247 
Moderate    Inter Info   
[2]
D0539
 
Duloxetine
 
C18H19NOS
 
60835 
Moderate    Inter Info   
[42], [43], [44], [45]
D0687
 
Fluvoxamine
 
C15H21F3N2O2
 
5324346 
Moderate    Inter Info   
[47], [48]
D0740
 
Grepafloxacin
 
C19H22FN3O3
 
72474 
Moderate    Inter Info   
[49]
D0793
 
Imatinib
 
C29H31N7O
 
5291 
Moderate    Inter Info   
[50]
D1075
 
Mirtazapine
 
C17H19N3
 
4205 
Moderate    Inter Info   
[56], [57], [58], [59], [60]
D1119
 
Nelfinavir
 
C32H45N3O4S
 
64143 
Moderate    Inter Info   
[62]
D1415
 
Ritonavir
 
C37H48N6O5S2
 
392622 
Moderate    Inter Info   
[65], [66], [67]
D1570
 
Theophylline
 
C7H8N4O2
 
2153 
Moderate    Inter Info   
[69], [70], [2]
D1706
 
Voriconazole
 
C16H14F3N5O
 
71616 
Moderate    Inter Info   
[17], [26], [80]
D1711
 
Warfarin
 
C19H16O4
 
54678486 
Moderate    Inter Info   
[81], [82], [2], [83]
D0002
 
Abametapir (topical)
 
C12H12N2
 
15664 
Moderate    Inter Info   
[84]
D0043
 
Alosetron
 
C17H18N4O
 
2099 
Moderate    Inter Info   
[85]
D0064
 
Aminophylline
 
C16H24N10O4
 
9433 
Moderate    Inter Info   
[69], [70], [2]
D0112
 
Asenapine
 
C17H16ClNO
 
3036780 
Moderate    Inter Info   
[88]
D0171
 
Berotralstat
 
C30H26F4N6O
 
137528262 
Moderate    Inter Info   
[90]
D0251
 
Capmatinib
 
C23H17FN6O
 
25145656 
Moderate    Inter Info   
[93]
D0386
 
Conivaptan
 
C32H26N4O2
 
151171 
Moderate    Inter Info   
[95]
D0413
 
Dalfopristin
 
C34H50N4O9S
 
6323289 
Moderate    Inter Info   
[97]
D0432
 
Deferasirox
 
C21H15N3O4
 
214348 
Moderate    Inter Info   
[98]
D0543
 
Duvelisib
 
C22H17ClN6O
 
50905713 
Moderate    Inter Info   
[99]
D0559
 
Eliglustat
 
C23H36N2O4
 
23652731 
Moderate    Inter Info   
[100]
D0638
 
Fedratinib
 
C27H36N6O3S
 
16722836 
Moderate    Inter Info   
[26], [104]
D0699
 
Fostamatinib
 
C23H26FN6O9P
 
11671467 
Moderate    Inter Info   
[105]
D0724
 
Givosiran
 
C78H139N11O30
 
119058042 
Moderate    Inter Info   
[106]
D0867
 
Itraconazole
 
C35H38Cl2N8O4
 
55283 
Moderate    Inter Info   
[108], [17], [109], [110], [111], [112], [25], [113], [114]
D0869
 
Ivacaftor
 
C24H28N2O3
 
16220172 
Moderate    Inter Info   
[115], [116], [117], [118]
D0894
 
Lapatinib
 
C29H26ClFN4O4S
 
208908 
Moderate    Inter Info   
[119]
D0896
 
Larotrectinib
 
C21H22F2N6O2
 
46188928 
Moderate    Inter Info   
[17], [26], [120]
D0899
 
Lefamulin
 
C28H45NO5S
 
25185057 
Moderate    Inter Info   
[121]
D0916
 
Levobupivacaine
 
C18H28N2O
 
92253 
Moderate    Inter Info   
[26], [122]
D0946
 
Lonafarnib
 
C27H31Br2ClN4O2
 
148195 
Moderate    Inter Info   
[123]
D1063
 
Mifepristone
 
C29H35NO2
 
55245 
Moderate    Inter Info   
[17], [26], [125], [126]
D1117
 
Nefazodone
 
C25H32ClN5O2
 
4449 
Moderate    Inter Info   
[127]
D1136
 
Nilotinib
 
C28H22F3N7O
 
644241 
Moderate    Inter Info   
[128]
D1160
 
Obeticholic acid
 
C26H44O4
 
447715 
Moderate    Inter Info   
[129]
D1189
 
Osilodrostat
 
C13H10FN3
 
44139752 
Moderate    Inter Info   
[131]
D1201
 
Oxtriphylline
 
C12H21N5O3
 
656652 
Moderate    Inter Info   
[69], [70], [2]
D1251
 
Pentoxifylline
 
C13H18N4O3
 
4740 
Moderate    Inter Info   
[133], [134]
D1299
 
Pirfenidone
 
C12H11NO
 
40632 
Moderate    Inter Info   
[26], [135]
D1378
 
Ramelteon
 
C16H21NO2
 
208902 
Moderate    Inter Info   
[136]
D1398
 
Ribociclib
 
C23H30N8O
 
44631912 
Moderate    Inter Info   
[137], [138], [139], [140], [141], [142], [143], [144], [145]
D1422
 
Roflumilast
 
C17H14Cl2F2N2O3
 
449193 
Moderate    Inter Info   
[26], [147], [148]
D1432
 
Rucaparib
 
C19H18FN3O
 
9931954 
Moderate    Inter Info   
[130]
D1444
 
Saquinavir
 
C38H50N6O5
 
441243 
Moderate    Inter Info   
[149], [150]
D1459
 
Selpercatinib
 
C29H31N7O3
 
134436906 
Moderate    Inter Info   
[26], [151]
D1505
 
Stiripentol
 
C14H18O3
 
5311454 
Moderate    Inter Info   
[26], [154], [155]
D1536
 
Tasimelteon
 
C15H19NO2
 
10220503 
Moderate    Inter Info   
[156]
D1544
 
Telithromycin
 
C43H65N5O10
 
3002190 
Moderate    Inter Info   
[157], [158]
D1660
 
Tucatinib
 
C26H24N8O2
 
51039094 
Moderate    Inter Info   
[161]
D1687
 
Vemurafenib
 
C23H18ClF2N3O3S
 
42611257 
Moderate    Inter Info   
[10]
D0069
 
Amlodipine
 
C20H25ClN2O5
 
2162 
Minor    Inter Info   
[2]
D0497
 
Diltiazem
 
C22H26N2O4S
 
39186 
Minor    Inter Info   
[2]
D0865
 
Isradipine
 
C19H21N3O5
 
3784 
Minor    Inter Info   
[2]
D1130
 
Nicardipine
 
C26H29N3O6
 
4474 
Minor    Inter Info   
[2]
D1138
 
Nimodipine
 
C21H26N2O7
 
4497 
Minor    Inter Info   
[2]
D1141
 
Nisoldipine
 
C20H24N2O6
 
4499 
Minor    Inter Info   
[2]
D1690
 
Verapamil
 
C27H38N2O4
 
2520 
Minor    Inter Info   
[2]
D0170
 
Bepridil
 
C24H34N2O
 
2351 
Minor    Inter Info   
[2]
D0911
 
Levamlodipine
 
C20H25ClN2O5
 
9822750 
Minor    Inter Info   
[2]
D1134
 
Nifedipine
 
C17H18N2O6
 
4485 
Minor    Inter Info   
[2]
   CYP450 enzyme induction Drug Num:  20
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0194
 
Bosentan
 
C27H29N5O6S
 
104865 
Moderate    Inter Info   
[40]
D0554
 
Efavirenz
 
C14H9ClF3NO2
 
64139 
Moderate    Inter Info   
[46]
D1128
 
Nevirapine
 
C15H14N4O
 
4463 
Moderate    Inter Info   
[17], [26], [63], [64]
D1494
 
Somatotropin
 
NA
 
NA
Moderate    Inter Info   
[17], [26], [68]
D1652
 
Troglitazone
 
C24H27NO5S
 
5591 
Moderate    Inter Info   
[73], [74], [75], [76], [77], [78], [79]
D0044
 
Alpelisib
 
C19H22F3N5O2S
 
56649450 
Moderate    Inter Info   
[86]
D0095
 
Apalutamide
 
C21H15F4N5O2S
 
24872560 
Moderate    Inter Info   
[26], [87]
D0204
 
Brigatinib
 
C29H39ClN7O2P
 
68165256 
Moderate    Inter Info   
[91]
D0300
 
Cenobamate
 
C10H10ClN5O2
 
11962412 
Moderate    Inter Info   
[94]
D0406
 
Dabrafenib
 
C23H20F3N5O2S2
 
44462760 
Moderate    Inter Info   
[26], [96]
D0578
 
Enzalutamide
 
C21H16F4N4O2S
 
15951529 
Moderate    Inter Info   
[101], [17], [26], [102]
D0628
 
Etravirine
 
C20H15BrN6O
 
193962 
Moderate    Inter Info   
[103]
D0953
 
Lorlatinib
 
C21H19FN6O2
 
71731823 
Moderate    Inter Info   
[124]
D1167
 
Olaparib
 
C24H23FN4O3
 
23725625 
Moderate    Inter Info   
[17], [26], [130]
D1190
 
Osimertinib
 
C28H33N7O2
 
71496458 
Moderate    Inter Info   
[132]
D1401
 
Rifapentine
 
C47H64N4O12
 
135403821 
Moderate    Inter Info   
[146], [83]
D1493
 
Somapacitan
 
C54H95N13O20S2
 
129894493 
Moderate    Inter Info   
[17], [26], [68]
D1495
 
Somatrem
 
C43H72N14O14
 
5487805 
Moderate    Inter Info   
[17], [26], [153], [68]
D1546
 
Telotristat ethyl
 
C27H26ClF3N6O3
 
25181577 
Moderate    Inter Info   
[26], [159]
D0106
 
Armodafinil
 
C15H15NO2S
 
9690109 
Minor    Inter Info   
[162], [163], [164], [165], [166]
   Competitive inhibition of metabolic enzyme Drug Num:  3
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1476
 
Sirolimus
 
C51H79NO13
 
5284616 
Moderate    Inter Info   
[152], [67]
D1526
 
Tacrolimus
 
C44H69NO12
 
445643 
Moderate    Inter Info   
[152], [67]
D1549
 
Temsirolimus
 
C56H87NO16
 
6918289 
Moderate    Inter Info   
[152], [67]
   Decreased metabolism (Unspecific) Drug Num:  11
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0173
 
Betaxolol
 
C18H29NO3
 
2369 
Moderate    Inter Info   
[2]
D0188
 
Bisoprolol
 
C18H31NO4
 
2405 
Moderate    Inter Info   
[2]
D0884
 
Labetalol
 
C19H24N2O3
 
3869 
Moderate    Inter Info   
[2]
D1049
 
Metoprolol
 
C15H25NO3
 
4171 
Moderate    Inter Info   
[2]
D1357
 
Propranolol
 
C16H21NO2
 
4946 
Moderate    Inter Info   
[2]
D1585
 
Timolol
 
C13H24N4O3S
 
33624 
Moderate    Inter Info   
[2]
D0010
 
Acebutolol
 
C18H28N2O4
 
1978 
Moderate    Inter Info   
[2]
D0267
 
Carvedilol
 
C24H26N2O4
 
2585 
Moderate    Inter Info   
[2]
D1114
 
Nebivolol
 
C22H25F2NO4
 
71301 
Moderate    Inter Info   
[2]
D1244
 
Penbutolol
 
C18H29NO2
 
37464 
Moderate    Inter Info   
[2]
D1293
 
Pindolol
 
C14H20N2O2
 
4828 
Moderate    Inter Info   
[2]
      Affected excretion pathways
   Decreased renal excretion (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1555
 
Terfenadine
 
C32H41NO2
 
5405 
Major    Inter Info   
[1], [2]
      Pharmacodynamic additive effects
   Increased risk of hepatotoxicity Drug Num:  19
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0900
 
Leflunomide
 
C12H9F3N2O2
 
3899 
Major    Inter Info   
[11], [12], [13]
D1073
 
Mipomersen
 
C230H324N67O122P19S19
 
118984467 
Major    Inter Info   
[15]
D1258
 
Pexidartinib
 
C20H15ClF3N5
 
25151352 
Major    Inter Info   
[16]
D1556
 
Teriflunomide
 
C12H9F3N2O2
 
54684141 
Major    Inter Info   
[11], [12], [13]
D0114
 
Asparaginase Escherichia coli
 
NA
 
NA
Moderate    Inter Info   
[29], [30], [31], [17], [26], [32], [33], [34], [35], [36], [37], [38], [39]
D0357
 
Clofarabine
 
C10H11ClFN5O3
 
119182 
Moderate    Inter Info   
[41]
D0826
 
Interferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[51], [52], [53], [54]
D0827
 
Interferon beta-1b
 
NA
 
NA
Moderate    Inter Info   
[51], [52], [53], [54]
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Moderate    Inter Info   
[26], [55]
D1106
 
Naltrexone
 
C20H23NO4
 
5360515 
Moderate    Inter Info   
[61]
D1234
 
Pegaspargase
 
C14H19NO
 
436058 
Moderate    Inter Info   
[29], [30], [31], [17], [26], [32], [33], [34], [35], [36], [37], [38], [39]
D1589
 
Tioguanine
 
C5H5N5S
 
2723601 
Moderate    Inter Info   
[71], [72]
D0113
 
Asparaginase Erwinia chrysanthemi
 
NA
 
NA
Moderate    Inter Info   
[29], [30], [31], [17], [26], [32], [33], [34], [35], [36], [37], [38], [39]
D0149
 
Bedaquiline
 
C32H31BrN2O2
 
5388906 
Moderate    Inter Info   
[89]
D0232
 
Calaspargase pegol
 
NA
 
NA
Moderate    Inter Info   
[29], [30], [31], [17], [26], [32], [33], [34], [35], [36], [37], [38], [39]
D0248
 
Cannabidiol
 
C21H30O2
 
644019 
Moderate    Inter Info   
[26], [92]
D0789
 
Idelalisib
 
C22H18FN7O
 
11625818 
Moderate    Inter Info   
[107]
D1239
 
Peginterferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[51], [52], [53], [54]
D1615
 
Trabectedin
 
C39H43N3O11S
 
108150 
Moderate    Inter Info   
[26], [160]
References
1 Awni WM, Cavanaugh JH, Leese P, Kasier J, Cao GL, Locke CS, Dube LM "The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine." Eur J Clin Pharmacol 52 (1997): 49-54. [PMID: 9143867]
2 Product Information. Zylo Filmtab (zileuton). Abbott Pharmaceutical, Abbott Park, IL.
3 Granfors MT, Backman JT, Laitila J, Neuvonen PJ "Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro." Br J Clin Pharmacol 57 (2004): 349-53. [PMID: 14998432]
4 Granfors MT, Backman JT, Neuvonen M, Ahonen J, Neuvonen PJ "Fluvoxamine drastically increases concentrations and effects of tizanidine: A potentially hazardous interaction." Clin Pharmacol Ther 75 (2004): 331-41. [PMID: 15060511]
5 Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ "Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism." Clin Pharmacol Ther 76 (2004): 598-606. [PMID: 15592331]
6 Momo K, Doki K, Hosono H, Homma M, Kohda Y "Drug interaction of tizanidine and fluvoxamine." Clin Pharmacol Ther 76 (2004): 509-10. [PMID: 15536467]
7 Momo K, Homma M, Kohda Y, Ohkoshi N, Yoshizawa T, Tamaoka A "Drug interaction of tizanidine and ciprofloxacin: Case report." Clin Pharmacol Ther 80 (2006): 717-9. [PMID: 17178273]
8 Product Information. Vioxx (rofecoxib). Merck & Co, Inc, West Point, PA.
9 Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
10 Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
11 Canadian Pharmacists Association.
12 EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
13 Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
14 Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
15 Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
16 Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
17 Cerner Multum, Inc. "Australian Product Information.".
18 Desta Z, Kerbusch T, Flockhart DA "Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)." Clin Pharmacol Ther 65 (1999): 10-20. [PMID: 9951426]
19 Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
20 Flockhart DA, Drici MD, Kerbusch T, et al "Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with tourette syndrome." J Clin Psychopharmacol 20 (2000): 317-24. [PMID: 10831018]
21 Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
22 Krahenbuhl S, Sauter B, Kupferschmidt H, Krause M, Wyss PA, Meier PJ "Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication." Am J Med Sci 309 (1995): 315-6. [PMID: 7771501]
23 Mangum EM, Graham KK "Lopinavir-Ritonavir: a new protease inhibitor." Pharmacotherapy 21 (2001): 1352-63. [PMID: 11714208]
24 Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
25 Product Information. Sporanox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
26 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
27 Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
28 Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
29 Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
30 Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
31 Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
32 Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
33 Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
34 Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
35 Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
36 Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
37 Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
38 Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
39 Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
40 Product Information. Tracleer (bosentan). Acetelion Pharmaceuticals US, Inc, South San Francisco, CA.
41 Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
42 Brosen K, Skjelbo E, Rasmussen BB, Poulsen HE, Loft S "Fluvoxamine is a potent inhibitor of cytochrome P4501A2." Biochem Pharmacol 45 (1993): 1211-4. [PMID: 8466541]
43 Martinez C, Albet C, Agundez JA, et al. "Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists." Clin Pharmacol Ther 65 (1999): 369-76. [PMID: 10223772]
44 Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
45 Uwe F, Strobl G, Manaut F, et al "Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isofaorm CYP1A2." Mol Pharmacol 43 (1993): 191-9. [PMID: 8429824]
46 Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
47 Damkier P, Hansen LL, Brosen K "Effect of fluvoxamine on the pharmacokinetics of quinidine." Eur J Clin Pharmacol 55 (1999): 451-6. [PMID: 10492058]
48 Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
49 Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
50 Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
51 Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
52 Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
53 Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
54 Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
55 Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
56 Okubo M, Murayama N, Miura J, Chiba Y, Yamazaki H "Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients." Biochem Pharmacol 93 (2015): 104-9. [PMID: 25475885]
57 Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
58 Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
59 Sitsen JM, Maris FA, Timmer CJ "Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects." Eur J Clin Pharmacol 56 (2000): 389-94. [PMID: 11009047]
60 Stormer E, von Moltke LL, Shader RI, Greenblatt DJ "Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4" Drug Metab Dispos 28 (2000): 1168-75. [PMID: 10997935]
61 Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
62 Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
63 Product Information. Viramune (nevirapine). Boehringer-Ingelheim, Ridgefield, CT.
64 Product Information. Viramune XR (nevirapine). Boehringer Ingelheim, Ridgefield, CT.
65 Olkkola KT, Palkama VJ, Neuvonen PJ "Ritonavir's role in reducing fentanyl clearance and prolonging its half-life." Anesthesiology 91 (1999): 681-5. [PMID: 10485779]
66 Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
67 Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
68 Product Information. Zorbtive (somatropin). Serono Laboratories Inc, Rockland, MA.
69 Granneman GR, Braeckman RA, Locke CS, Cavanaugh JH, Dube LM, Awni WM "Effect of zileuton on theophylline pharmacokinetics." Clin Pharmacokinet 29(suppl 2 (1995): 77-83. [PMID: 8620674]
70 Lau R "Drug interactions with zileuton." Lancet 349 (1997): 1479-80. [PMID: 9164345]
71 Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
72 Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
73 Burgess SJ, Singer GG, Brennan DC "Effect of troglitazone on cyclosporine whole blood levels." Transplantation 66 (1998): 272. [PMID: 9701278]
74 Frantz RP, Nguyen TT "Rezulin (troglitazone) greatly increases cyclosporine metabolism." J Heart Lung Transplant 17 (1998): 1037-8. [PMID: 9811416]
75 Fraser CG, Fierro L "Comment: troglitazone." Ann Pharmacother 32 (1998): 1111-2. [PMID: 9793612]
76 Kaplan B, Friedman G, Jacobs M, Viscuso R, Lyman N, DeFranco P, Bonomini L, Mulgaonkar SP "Potential interaction of troglitazone and cyclosporine." Transplantation 65 (1998): 1399-400. [PMID: 9625027]
77 Park MH, Pelegrin D, Haug MT, Young JB "Troglitazone, a new antidiabetic agent, decreases cyclosporine level." J Heart Lung Transplant 17 (1998): 1139-40. [PMID: 9855455]
78 Product Information. Rezulin (troglitazone). Parke-Davis, Morris Plains, NJ.
79 Terra SG, Washam JB, May DB "Comment: troglitazone drug interactions." Ann Pharmacother 32 (1998): 1111. [PMID: 9793611]
80 Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
81 Awni WM, Hussein Z, Granneman GR, Patterson KJ, Dube LM, Cavanaugh JH "Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humans." Clin Pharmacokinet 29(suppl 2 (1995): 67-76. [PMID: 8620673]
82 Lu P, Schrag ML, Slaughter DE, Raab CE, Shou M, Rodrigues AD "Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor." Drug Metab Dispos 31 (2003): 1352-60. [PMID: 14570767]
83 Thijssen HH, Flin ois JP, Beaune PH "Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes." Drug Metab Dispos 28 (2000): 1284-90. [PMID: 11038154]
84 Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
85 Product Information. Lotronex (alosetron). Glaxo Wellcome, Research Triangle Park, NC.
86 Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
87 Product Information. Erleada (apalutamide). Janssen Biotech, Inc., Horsham, PA, PA.
88 Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
89 Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
90 Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
91 Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
92 Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
93 Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
94 Product Information. Xcopri (cenobamate). SK Life Science, Inc., Paramus, NJ.
95 Product Information. Vaprisol (conivaptan). Cumberland Pharmaceuticals Inc, Nashville, TN.
96 Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
97 Product Information. Synercid (dalfopristin-quinupristin) Rhone-Poulenc Rorer, Collegeville, PA.
98 Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
99 Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
100 Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
101 Benoist G, van Oort I, et al "Drug-drug interaction potential in men treated with enzalutamide: Mind the gap." Br J Clin Pharmacol 0 (2017): epub. [PMID: 28881501]
102 Product Information. Xtandi (enzalutamide). Astellas Pharma US, Inc, Deerfield, IL.
103 Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
104 Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
105 Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
106 Product Information. Givlaari (givosiran). Alnylam Pharmaceuticals, Cambridge, MA.
107 Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
108 Auclair B, Berning SE, Huitt GA, Peloquin CP "Potential interaction between itraconazole and clarithromycin." Pharmacotherapy 19 (1999): 1439-44. [PMID: 10600094]
109 Chiba M, Hensleigh M, Nishime JA, Balani SK, Lin JH "Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor." Drug Metab Dispos 24 (1996): 307-14. [PMID: 8820421]
110 Gillies J, Hung KA, Fitzsimons E, Soutar R "Severe vincristine toxicity in combination with itraconazole." Clin Lab Haematol 20 (1998): 123-4. [PMID: 9681224]
111 Kaukonen KM, Olkkola KT, Neuvonen PJ "Itraconazole increases plasma concentrations of quinidine." Clin Pharmacol Ther 62 (1997): 510-7. [PMID: 9390107]
112 Lukkari E, Juhakoski A, Aranko K, Neuvonen PJ "Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metabolite." Eur J Clin Pharmacol 52 (1997): 403-6. [PMID: 9272412]
113 Tailor SAN "Peripheral edema due to nifedipine-itraconazole interaction: a case report." Arch Dermatol 132 (1996): 1374. [PMID: 8607648]
114 Varis T, Kaukonen KM, Kivisto KT, Neuvonen PJ "Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole." Clin Pharmacol Ther 64 (1998): 363-8. [PMID: 9797792]
115 Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
116 Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
117 Product Information. Symdeko 4-Week (ivacaftor-tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
118 Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
119 Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
120 Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
121 Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
122 Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
123 Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
124 Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
125 He K, Woolf TF, Hollenberg PF "Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486)." J Pharmacol Exp Ther 288 (1999): 791-7. [PMID: 9918590]
126 Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
127 Product Information. Serzone (nefazodone). Bristol-Myers Squibb, Princeton, NJ.
128 Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
129 Product Information. Ocaliva (obeticholic acid). Intercept Pharmaceuticals, Inc., New York, NY.
130 EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
131 Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
132 Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
133 Magnusson M, Bergstrand IC, Bjorkman S, Heijl A, Roth B, Hoglund P "A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans." Br J Clin Pharmacol 61 (2006): 138-47. [PMID: 16433868]
134 Product Information. Trental (pentoxifylline). Hoechst Marion-Roussel Inc, Kansas City, MO.
135 Product Information. Esbriet (pirfenidone). Intermune Inc, Brisbane, CA.
136 Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
137 DSouza DL, Levasseur LM, Nezamis J, Robbins DK, Simms L, Koch KM "Effect of alosetron on the pharmacokinetics of alprazolam." J Clin Pharmacol 41 (2001): 452-4. [PMID: 11304902]
138 Kane GC, Lipsky JJ "Drug-grapefruit juice interactions." Mayo Clin Proc 75 (2000): 933-42. [PMID: 10994829]
139 Katoh M, Nakajima M, Yamazaki H, Yokoi T "Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport." Eur J Pharm Sci 12 (2001): 505-13. [PMID: 11231118]
140 Nagy J, Schipper HG, Koopmans RP, Butter JJ, van Boxtel CJ, Kager PA "Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability." Am J Trop Med Hyg 66 (2002): 260-3. [PMID: 12139218]
141 Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
142 Rawden HC, Kokwaro GO, Ward SA, Edwards G "Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes." Br J Clin Pharmacol 49 (2000): 313-22. [PMID: 10759686]
143 Trivier JM, Libersa C, Belloc C, Lhermitte M "Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P450 3A enzymes (first report)." Life Sci 52 (1993): pl91-6. [PMID: 8445979]
144 Yu DK "The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions." J Clin Pharmacol 39 (1999): 1203-11. [PMID: 10586385]
145 Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P, Rahmani R "Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions." Biochem Pharmacol 45 (1993): 853-61. [PMID: 8452560]
146 Product Information. Priftin (rifapentine). Hoechst Marion-Roussel Inc, Kansas City, MO.
147 Product Information. Daliresp (roflumilast). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
148 Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
149 Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
150 Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
151 Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
152 Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
153 Product Information. Humatrope (somatropin). Lilly, Eli and Company, Indianapolis, IN.
154 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
155 Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
156 Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
157 Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
158 European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
159 Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
160 Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
161 Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
162 Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
163 Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
164 Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
165 Robertson P Jr, Hellriegel ET, Arora S, Nelson M "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers." Clin Pharmacol Ther 71 (2002): 46-56. [PMID: 11823757]
166 Robertson P, Decory HH, Madan A, Parkinson A "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos 28 (2000): 664-71. [PMID: 10820139]